NCT05297708

Brief Summary

This will be a prospective observational study. The population would be pediatric patients 6 years to \<19 years of age who were referred for elevated blood pressure to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, white coat hypertension) as accurately as ambulatory blood pressure monitor (ABPM) in childhood and adolescence.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
4mo left

Started Mar 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Mar 2022Sep 2026

First Submitted

Initial submission to the registry

March 17, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

March 24, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 28, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

4.2 years

First QC Date

March 17, 2022

Last Update Submit

June 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determine blood pressure phenotype

    The primary objective of this study is to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, white coat hypertension) as accurately as ambulatory blood pressure monitor (ABPM) in childhood and adolescence.

    6-12 months after enrollment

Secondary Outcomes (1)

  • HBP correlation with end organ damage

    6-12 months after enrollment

Study Arms (1)

All Participants

he population would be pediatric patients 6 years to \<19 years of age who were referred for elevated blood pressure. At the initial clinic visit, the participant will be consented and a thorough history will be taken. An ECHO and non-invasive vascular measurements will be taken (central BP, augmentation index, pulse wave velocity). Patients will have an ambulatory blood pressure monitor (ABPM) placed and be trained to use a home blood pressure monitor (HBP) which will be sent home with them. The monitors in this study are FDA-approved and are being used as indicated. After one day at home, patients will return the ABPM via mail and continue to take measurements with the HBP for 20 days.

Eligibility Criteria

Age6 Years - 19 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The population will be pediatric patients 6 years to \<19 years years of age who were referred for elevated blood pressure to the Recruitment Hypertension clinic, Lipid Clinic, or Center for Better Health and Nutrition.

You may qualify if:

  • Age 6 years to \<19 years old;
  • Elevated blood pressure defined as 15% lower than the 95%ile BP based on clinical practice guidelines(CPG) but less than stage II hypertension based on CPG;
  • Tolerate ABPM 24 hours;
  • Tolerate HBP; and
  • Can have diabetes mellitus, obstructive sleep apnea, and attention deficit hyperactivity disorder managed by medication.
  • On stable doses of medications known to affect BP such as:
  • Corticosteroids
  • Calcineurin inhibitors
  • Oral decongestants;
  • Clinically stable

You may not qualify if:

  • On antihypertension medications or treated in the last 6 months;
  • Pregnant;
  • Structural heart disease such as:
  • Obstructive valvular disease
  • Coarctation of the aorta
  • Cardiomyopathy;
  • Other secondary causes such as:
  • Renal artery stenosis
  • Neurological condition with dysautonomia;
  • Recent initiation of medications known to affect BP such as:
  • Corticosteroids
  • Calcineurin inhibitors
  • Oral decongestants;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Children's Hospital

Cincinnati, Ohio, 45229, United States

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Elaine Urbina

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2022

First Posted

March 28, 2022

Study Start

March 24, 2022

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

June 19, 2025

Record last verified: 2025-06

Locations